Resources

This study examines factors associated with receptive injection equipment sharing among people who inject drugs in the context of COVID-19.

Although stigma reduction is a key goal of federal strategies to prevent overdose, there is limited data to assess progress made in reducing use of stigmatizing language about addiction.

This study examined whether an online training incorporating patient narratives reduced primary care clinicians' (PCCs) stigma toward people with opioid use disorder (primary) and increased intenti

While daily witnessed opioid agonist treatment (OAT) ingestion is common in British Columbia (BC), Canada, and elsewhere, sparse evidence supports this resource-intensive practice.

We developed a survey to assess clinician self-reported barriers, perceptions, and practices for treating HCV-infected patients with SUD and the associations of these barriers, perceptions, and pra

We conducted a process evaluation of a novel harm reduction-oriented addiction medicine consultation team [AMCT].

Using our research findings, we explore Harm Reduction and Methadone Maintenance Treatment (MMT) using an intersectional lens to provide a more complex understanding of Harm Reduction and MMT, part

Co-use of stimulants and opioids is rapidly increasing.

This study aims to explore the experiences of patients receiving depot buprenorphine from an Australian publicly operated drug and alcohol service.

PROFAN, a peer-led overdose prevention initiative, was successfully implemented in Montreal, Quebec, for people who use drugs (PWUD), or those likely to witness overdoses.

We sought to compare timely access to methadone treatment in the United States (US) and Canada during the COVID-19 pandemic.